neximmune.com (NEXI) - Volume dana dhuwit perusahaan

Simbol resmi perusahaan NexImmune, Inc. (NEXI)

NexImmune, Inc. (NEXI) develops AIM AI systems for T-cell stimulation while adhering to strict FDA regulations regarding biomaterial utilization. Management's key priority remains the advancement of personalized immunotherapy through clinical trials. The GURU.Markets portal features a chart of the organization's cash balance dynamics, where the current value is recorded at 0.00, confirming the issuer's current liquidity position.

NEXI - Cadangan dhuwit perusahaan NexImmune Corp ing rentang 04.07.2022 - 04.08.2024

Rincian analitis perusahaan NexImmune, Inc.

- rega saiki lan proyeksi nilai saham:
Pambiji fundamental perusahaan:NexImmune Inc NEXI
Produk merek NexImmune

This indicator determines the volume of liquid funds available for operational management and the generation of interest income. By analyzing the company's cash assets, an investor assesses the issuer's ability to maintain financial stability without external borrowing. The metric captures the balance between savings deposits and current expenses. For NexImmune, Inc. (NEXI), this reserve is critical for the uninterrupted maintenance of laboratories. Stable R&D funding allows elite immunologists to focus on developing cancer cell therapy.

Pesaing NexImmune, Inc. (NEXI)

Dhuwit awis perusahaan IBRX (ImmunityBio Corp)|Gunggung dana dhuwit perusahaan IMCR|Volume dana dhuwit perusahaan JANX (Janux Therapeutics, Inc.)|Sisa dhuwit perusahaan RCUS|zymeworks.com - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Tango Therapeutics Corp|Iovance Biotherapeutics (IOVA) - Dana dhuwit perusahaan|Immatics N.V. - Sisa dhuwit perusahaan|XNCR (xencor.com) - Volume dana dhuwit perusahaan|Volume dana dhuwit perusahaan Compass Therapeutics Inc|Dana dhuwit perusahaan Replimune (REPL)|LYEL: Total volume dana dhuwit perusahaan|Innate Pharma SA - Dhuwit awis perusahaan|Pyxis Oncology, Inc. (PYXS) - Cadangan dhuwit perusahaan|Compugen - Volume dana dhuwit perusahaan|Aset likuid perusahaan IO Biotech Inc IOBT|STRO (Sutro Biopharma Inc.) - Dhuwit awis perusahaan|INKT - Aset likuid perusahaan|Dana dhuwit perusahaan werewolftx.com|Dhuwit awis perusahaan Immix Biopharma, Inc. (IMMX)|Dhuwit awis perusahaan ALXO (ALX Oncology Holdings)|Dana dhuwit perusahaan CUE (Cue Biopharma)|Volume dana dhuwit perusahaan PDSB (PDS Biotechnology Corp)|sonnetbio.com (SONN) - Cadangan dhuwit perusahaan|MAIA Biotechnology - Volume dana dhuwit perusahaan|LIMN - Volume dana dhuwit perusahaan|LVTX: Volume dana dhuwit perusahaan|NextCure - Sisa dhuwit perusahaan|LPTX (Leap Therapeutics Inc) - Volume dana dhuwit perusahaan|INTS (Intensity Therapeutics, Inc.) - Gunggung dana dhuwit perusahaan|Volume dana dhuwit perusahaan SNSE|Dana dhuwit perusahaan TOVX (Theriva Biologics, Inc.)|Gritstone bio, Inc. - Dhuwit awis perusahaan|Volume dana dhuwit perusahaan Kineta KA|turnstonebio.com - Volume dana dhuwit perusahaan|VCNX (Vaccinex, Inc) - Dhuwit awis lan setara dhuwit awis perusahaan|Harpoon Therapeutics (HARP) - Dana dhuwit perusahaan